Skip to main content

Starling Oncology, Inc 10-Q for FY2024 Q1

Starling Oncology, Inc. (STLN)

10-Q 2024-05-14 For: 2024-03-31
View Original
Added on April 06, 2026

About this 10-Q

Starling Oncology, Inc filed this 10-Q on May 14, 2024, covering the quarter ended March 31, 2024 (FY2024 Q1).

Headline figures

Quarter ended March 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$94.67M
up 24.2% from $76.19M a year earlier
Net loss
$19.89M
compared with a net loss of $30M a year earlier
Diluted EPS
-$0.22
compared with -$0.33 a year earlier